Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Gastric Cancer

Free Subscription Articles published in Br J Surg Retrieve available abstracts of 50 articles: HTML format

Single Articles

July 2024
1. BRANDL A, van Sandick JW
   Treatment of gastric cancer peritoneal metastases: role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
   Br J Surg. 2024;111:znae149.
   PubMed    
   
   
   
2. XIE D, Shen J, Gong J
   Author response to: Comment on: Randomized clinical trial on D2 lymphadenectomy versus D2 lymphadenectomy plus complete mesogastric excision in patients undergoing gastrectomy for cancer (DCGC01 study).
   Br J Surg. 2024;111:znae157.
   PubMed    
   
   
   
3. LIANG X, Wu J, Yu H
   Comment on: Randomized clinical trial on D2 lymphadenectomy versus D2 lymphadenectomy plus complete mesogastric excision in patients undergoing gastrectomy for cancer (DCGC01 study).
   Br J Surg. 2024;111:znae156.
   PubMed    
   
   
   
4. BROWN LR, Crumley AB, Skipworth RJE
   Author response to: Comment on: Cachexia index for prognostication in surgical patients with locally advanced oesophageal or gastric cancer: multicentre cohort study.
   Br J Surg. 2024;111:znae173.
   PubMed    
   
   
   
5. ARKLE TS, Sivarajan SG, Penney NC, Rafiee H, et al
   Comment on: Cachexia index for prognostication in surgical patients with locally advanced oesophageal or gastric cancer: multicentre cohort study.
   Br J Surg. 2024;111:znae172.
   PubMed    
   
   
   June 2024
6. ZHANG W, Huang J
   Comment on: Randomized clinical trial on D2 lymphadenectomy versus D2 lymphadenectomy plus complete mesogastric excision in patients undergoing gastrectomy for cancer (DCGC01 study).
   Br J Surg. 2024;111:znae145.
   PubMed    
   
   
   
7. XIE D, Shen J, Gong J
   Author response to: Comment on: Randomized clinical trial on D2 lymphadenectomy versus D2 lymphadenectomy plus complete mesogastric excision in patients undergoing gastrectomy for cancer (DCGC01 study).
   Br J Surg. 2024;111:znae146.
   PubMed    
   
   
   May 2024
8. ZAFFARONI G, Mannucci A, Koskenvuo L, de Lacy B, et al
   Updated European guidelines for clinical management of familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), gastric adenocarcinoma, proximal polyposis of the stomach (GAPPS) and other rare adenomatous polyposis syndromes: a joint EH
   Br J Surg. 2024;111:znae070.
   PubMed     Abstract available
   
   
   
9. GUCHELAAR NAD, Nasserinejad K, Mostert B, Koolen SLW, et al
   Intraperitoneal chemotherapy for peritoneal metastases of gastric origin: a systematic review and meta-analysis.
   Br J Surg. 2024;111:znae116.
   PubMed     Abstract available
   
   
   
10. XIE D, Shen J, Liu L, Cao B, et al
    Randomized clinical trial on D2 lymphadenectomy versus D2 lymphadenectomy plus complete mesogastric excision in patients undergoing gastrectomy for cancer (DCGC01 study).
    Br J Surg. 2024;111:znae106.
    PubMed     Abstract available
    
    
    
11. LI K, Leng X, Han Y, Peng L, et al
    Comment on: Cachexia index for prognostication in surgical patients with locally advanced oesophageal or gastric cancer: multicentre cohort study.
    Br J Surg. 2024;111:znae136.
    PubMed    
    
    
    
12. BROWN LR, Crumley AB, Skipworth RJE
    Author response to: Comment on: Cachexia index for prognostication in surgical patients with locally advanced oesophageal or gastric cancer: multicentre cohort study.
    Br J Surg. 2024;111:znae135.
    PubMed    
    
    
    April 2024
13. BROWN LR, Thomson GG, Gardner E, Chien S, et al
    Cachexia index for prognostication in surgical patients with locally advanced oesophageal or gastric cancer: multicentre cohort study.
    Br J Surg. 2024;111:znae098.
    PubMed     Abstract available
    
    
    
14. SCHNEIDER MA, Gutschow CA
    Author response to: Comment on: Defining benchmarks for total and distal gastrectomy: global multicentre analysis.
    Br J Surg. 2024;111:znae079.
    PubMed    
    
    
    January 2024
15. LIU W, Chen X, Zhou Z, Chen Y, et al
    Reinforcement of the stapled duodenal stump during laparoscopic gastrectomy.
    Br J Surg. 2024;111:znad305.
    PubMed    
    
    
    
16. 
    Erratum to: Long-term oncological outcomes of robotic versus laparoscopic gastrectomy for gastric cancer: multicentre cohort study.
    Br J Surg. 2024;111:znae025.
    PubMed    
    
    
    
17. SCHNEIDER MA, Kim J, Berlth F, Sugita Y, et al
    Defining benchmarks for total and distal gastrectomy: global multicentre analysis.
    Br J Surg. 2024;111:znad379.
    PubMed    
    
    
    
18. LI ZY, Wei B, Zhou YB, Li TY, et al
    Long-term oncological outcomes of robotic versus laparoscopic gastrectomy for gastric cancer: multicentre cohort study.
    Br J Surg. 2024;111:znad435.
    PubMed     Abstract available
    
    
    September 2023
19. BAUSYS A, Luksta M, Anglickiene G, Maneikiene VV, et al
    Effect of home-based prehabilitation on postoperative complications after surgery for gastric cancer: randomized clinical trial.
    Br J Surg. 2023 Sep 26:znad312. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2023
20. MARKAR SR, Guazzelli A, Taylor A, Jones LL, et al
    Protocol for open-label randomized clinical trial of intensive surveillance versus standard postoperative follow-up in patients undergoing surgical resection for oesophageal and gastric cancer.
    Br J Surg. 2023 Jun 28:znad180. doi: 10.1093.
    PubMed    
    
    
    
21. VAN DIEREN JM, van der Post RS, Bisseling TM
    Shifting perceptions on endoscopic surveillance and timing of prophylactic gastrectomy for hereditary diffuse gastric cancer.
    Br J Surg. 2023 Jun 24:znad192. doi: 10.1093.
    PubMed    
    
    
    March 2023
22. BAXTER MA, Khan KS, Gall LS, Samuelson C, et al
    Diagnosis, treatment, and outcome of patients with oesophagogastric cancer during the COVID-19 pandemic: national study.
    Br J Surg. 2023;110:456-461.
    PubMed     Abstract available
    
    
    
23. PUCHER PH, Park MH, Cromwell DA, Crosby TC, et al
    Diagnosis and treatment for gastro-oesophageal cancer in England and Wales: analysis of the National Oesophago-Gastric Cancer Audit (NOGCA) database 2012-2020.
    Br J Surg. 2023 Mar 27:znad065. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2023
24. PARK SH, Hyung WJ, Yang HK, Park YK, et al
    Standard follow-up after curative surgery for advanced gastric cancer: secondary analysis of a multicentre randomized clinical trial (KLASS-02).
    Br J Surg. 2023 Feb 1:znad002. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2022
25. KUROKAWA Y, Doki Y, Mizusawa J, Yoshikawa T, et al
    Five-year follow-up of a randomized clinical trial comparing bursectomy and omentectomy alone for resectable gastric cancer (JCOG1001).
    Br J Surg. 2022 Nov 12. pii: 6825225. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2022
26. SILVA ANS, Saito Y, Yoshikawa T, Oshima T, et al
    Author response to: Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma.
    Br J Surg. 2022;109:e106.
    PubMed    
    
    
    
27. LIU K, Hu JK
    Comment on: Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma.
    Br J Surg. 2022;109:e105.
    PubMed    
    
    
    July 2022
28. LIU K, Zhang WH, Hu JK
    Comment on: Impact of postoperative chemotherapy on survival for oesophagogastric adenocarcinoma after preoperative chemotherapy and surgery.
    Br J Surg. 2022;109:e91.
    PubMed    
    
    
    
29. RAHMAN SA, Underwood TJ
    Author response to: Impact of postoperative chemotherapy on survival for oesophagogastric adenocarcinoma after preoperative chemotherapy and surgery.
    Br J Surg. 2022;109:e92.
    PubMed    
    
    
    February 2022
30. SILVA ANS, Saito Y, Yoshikawa T, Oshima T, et al
    Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma.
    Br J Surg. 2022;109:291-297.
    PubMed     Abstract available
    
    
    
31. RAHMAN S, Thomas B, Maynard N, Park MH, et al
    Impact of postoperative chemotherapy on survival for oesophagogastric adenocarcinoma after preoperative chemotherapy and surgery.
    Br J Surg. 2022;109:227-236.
    PubMed     Abstract available
    
    
    November 2021
32. RAHMAN SA, Maynard N, Trudgill N, Crosby T, et al
    Prediction of long-term survival after gastrectomy using random survival forests.
    Br J Surg. 2021;108:1341-1350.
    PubMed     Abstract available
    
    
    October 2021
33. CHMELO J, Phillips AW, Greystoke A, Bradshaw A, et al
    Comparison of the effects of FLOT and ECX chemotherapy for oesophagogastric adenocarcinoma on cardiopulmonary reserve.
    Br J Surg. 2021;108:e328-e329.
    PubMed    
    
    
    September 2021
34. ZHENG-YAN L, Feng Q, Yan S, Ji-Peng L, et al
    Learning curve of robotic distal and total gastrectomy.
    Br J Surg. 2021;108:1126-1132.
    PubMed     Abstract available
    
    
    
35. BONNOT PE, Lintis A, Mercier F, Benzerdjeb N, et al
    Prognosis of poorly cohesive gastric cancer after complete cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (CYTO-CHIP study).
    Br J Surg. 2021 Sep 9. pii: 6366963. doi: 10.1093.
    PubMed     Abstract available
    
    
    
36. PARK DJ, Kim YW, Yang HK, Ryu KW, et al
    Short-term outcomes of a multicentre randomized clinical trial comparing laparoscopic pylorus-preserving gastrectomy with laparoscopic distal gastrectomy for gastric cancer (the KLASS-04 trial).
    Br J Surg. 2021 Sep 6. pii: 6364812. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2021
37. ALKHAFFAF B, Metryka A, Blazeby JM, Glenny AM, et al
    Core outcome set for surgical trials in gastric cancer (GASTROS study): international patient and healthcare professional consensus.
    Br J Surg. 2021 Jun 24. pii: 6308782. doi: 10.1093.
    PubMed     Abstract available
    
    
    
38. PHILLIPS AW, Griffin SM
    Three decades of oesophagogastric cancer care: now a curable disease.
    Br J Surg. 2021;108:595-597.
    PubMed    
    
    
    May 2021
39. JIN C, Jiang Y, Yu H, Wang W, et al
    Deep learning analysis of the primary tumour and the prediction of lymph node metastases in gastric cancer.
    Br J Surg. 2021;108:542-549.
    PubMed     Abstract available
    
    
    March 2021
40. KOEMANS WJ, van der Kaaij RT, van Sandick JW
    Reply to Correspondence to "Treatment of PERItoneal dissemination in Stomach Cancer patients with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy (HIPEC): first results of the PERISCOPE I study".
    Br J Surg. 2021;108:e94.
    PubMed    
    
    
    
41. CHIU CC, Lee PH, Chang CS, Rau KM, et al
    Correspondence to 'Treatment of PERItoneal disease in Stomach Cancer with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy: PERISCOPE I initial results'.
    Br J Surg. 2021;108:e93.
    PubMed    
    
    
    January 2021
42. KAMARAJAH SK, Navidi M, Phillips AW
    Response to "Comment on: Impact of anastomotic leak on long-term survival in patients undergoing gastrectomy for gastric cancer".
    Br J Surg. 2021 Jan 31. pii: 6124825. doi: 10.1093.
    PubMed    
    
    
    
43. HU Q, Sun Y, Yang X
    Comment on: Impact of anastomotic leak on long-term survival in patients undergoing gastrectomy for gastric cancer.
    Br J Surg. 2021 Jan 31. pii: 6124822. doi: 10.1093.
    PubMed    
    
    
    November 2020
44. LIU Y, Yang T, Wei YW
    What is the difference between overall survival, recurrence-free survival and time-to-recurrence?
    Br J Surg. 2020;107:e634.
    PubMed    
    
    
    October 2020
45. HUANG J, Yang B, Tan J, Zhou S, et al
    Gastric cancer nodal tumour-stroma ratios influence prognosis.
    Br J Surg. 2020 Oct 14. doi: 10.1002/bjs.12054.
    PubMed     Abstract available
    
    
    
46. JESTIN HANNAN C, Linder G, Kung CH, Johansson J, et al
    Geographical differences in cancer treatment and survival for patients with oesophageal and gastro-oesophageal junctional cancers.
    Br J Surg. 2020;107:1500-1509.
    PubMed     Abstract available
    
    
    
47. VAN DER KAAIJ RT, Wassenaar ECE, Koemans WJ, Sikorska K, et al
    Treatment of PERItoneal disease in Stomach Cancer with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy: PERISCOPE I initial results.
    Br J Surg. 2020;107:1520-1528.
    PubMed     Abstract available
    
    
    September 2020
48. JIN C, Jiang Y, Yu H, Wang W, et al
    Deep learning analysis of the primary tumour and the prediction of lymph node metastases in gastric cancer.
    Br J Surg. 2020 Sep 29. doi: 10.1002/bjs.11928.
    PubMed     Abstract available
    
    
    August 2020
49. LIN JP, Zhao YJ, He QL, Hao HK, et al
    Adjuvant chemotherapy for patients with gastric neuroendocrine carcinomas or mixed adenoneuroendocrine carcinomas.
    Br J Surg. 2020;107:1163-1170.
    PubMed     Abstract available
    
    
    February 2020
50. LU J, Zhao YJ, Zhou Y, He Q, et al
    Modified staging system for gastric neuroendocrine carcinoma based on American Joint Committee on Cancer and European Neuroendocrine Tumor Society systems.
    Br J Surg. 2020;107:248-257.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.